Q-omics provides the consensus-scored RN7SL196P profile across patient tissues and cancer cell-line models. RN7SL196P expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RN7SL196P RNA expression shows 1,870 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where RN7SL196P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RN7SL196P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RN7SL196P survival associations across molecular data types. RN7SL196P RNA expression shows survival associations in the most cancer types (5). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RN7SL196P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	5	LUSC (72)	view →

This table ranks reproducible RN7SL196P RNA expression–survival associations across cancer types. High RN7SL196P expression shows unfavorable associations in LUSC, BRCA, LGG and SARC, but favorable associations in STAD. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify LUSC as the clearest survival context for RN7SL196P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.140	0.743	.001	72	view →
BRCA	DFS	Tertile	III,IV	0.201	0.796	.001	18	view →
LGG	DFS	Tertile	All	0.089	0.833	<.001	18	view →
STAD	OS	Tertile	II,III,IV	1.000	0.355	.029	15	view →
SARC	DFS	Tertile	All	0.210	0.597	.028	9	view →

Pink = unfavorable, green = favorable. all 5 lineages →

RN7SL196P-LUSC (OS)

Kaplan–Meier survival curve for RN7SL196P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RN7SL196P in patient tissues and cancer cell lines. In patient samples, RN7SL196P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	1,870	STAD (1822)	view →
RNA	667	STAD (250)	view →